Inolaxol vs Vi Siblin: Side-by-Side Comparison
Quick answer: Inolaxol and Vi Siblin are both bulk-forming laxative used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Inolaxol | Vi Siblin |
|---|---|---|
| Drug class | Bulk-forming laxative | Bulk-forming laxative |
| ATC code | A06AC | A06AC01 |
| Primary indications | Constipation, Irritable bowel syndrome | Constipation, Irritable bowel syndrome |
| Mechanism | Sterculia gum absorbs water in the gut to increase stool bulk and stimulate peristalsis | Ispaghula husk (psyllium) absorbs water in the intestine, increasing stool bulk and stimulating peristalsis |
| Common dose | 1 sachet 1-3 times daily with water | 3.5-7 g once or twice daily with water |
| Detail page | Inolaxol details → | Vi Siblin details → |
How to choose between Inolaxol and Vi Siblin
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Bulk-forming laxative on iMedic · Inolaxol full details · Vi Siblin full details
Frequently asked questions
Is Inolaxol better than Vi Siblin?
Neither is universally 'better.' They are both bulk-forming laxative with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Inolaxol to Vi Siblin?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Inolaxol and Vi Siblin have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Inolaxol and Vi Siblin available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.